Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease

被引:3
|
作者
Slowik, Voytek [1 ]
Wasserkrug, Heather [1 ]
Fischer, Ryan T. [1 ]
Connelly, Mark [2 ]
Deacy, Amanda D. [1 ,2 ]
Hampl, Sarah [3 ,4 ]
Daniel, James F. [1 ]
机构
[1] Univ Missouri, Div Pediat Gastroenterol, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[2] Univ Missouri, Div Dev & Behav Hlth, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[3] Univ Missouri, Div Gen Acad Pediat, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[4] Univ Missouri, Ctr Childrens Hlth Lifestyles & Nutr, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 02期
关键词
OF-THE-LITERATURE; ADOLESCENT OVERWEIGHT; OBESITY; INTERVENTION; CHILDREN; OUTCOMES; MOTIVATION; ATTENDANCE; RISK;
D O I
10.1111/cts.12913
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment x time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 50 条
  • [31] Management of Pediatric Nonalcoholic Fatty Liver Disease by Academic Hepatologists in Canada: A Nationwide Survey
    Mouzaki, Marialena
    Ling, Simon C.
    Schreiber, Richard A.
    Kamath, Binita M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (04) : 380 - 383
  • [32] Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management An Updated Systematic Review and Meta-analysis
    Nemati, Arefe
    Nikniaz, Zeinab
    Mota, Ali
    TOPICS IN CLINICAL NUTRITION, 2023, 38 (02) : 144 - 160
  • [33] Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
    Jung, Inha
    Koo, Dae-Jeong
    Lee, Mi Yeon
    Moon, Sun Joon
    Kwon, Hyemi
    Park, Se Eun
    Rhee, Eun-Jung
    Lee, Won-Young
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (04) : 845 - 854
  • [34] Down Syndrome and Pediatric Nonalcoholic Fatty Liver Disease: A Causal or Casual Relationship?
    De Matteo, Antonia
    Vajro, Pietro
    JOURNAL OF PEDIATRICS, 2017, 189 : 11 - 13
  • [35] Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
    Basaranoglu, Metin
    Ormeci, Necati
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02) : 127 - 132
  • [36] Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
    Basu, Rita
    Noureddin, Mazen
    Clark, Jeanne M.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (09) : 1700 - 1716
  • [37] Pediatric nonalcoholic fatty liver disease:A clinical and laboratory challenge
    Lucia Pacifico
    Eleonora Poggiogalle
    Vito Cantisani
    Guendalina Menichini
    Paolo Ricci
    Flavia Ferraro
    Claudio Chiesa
    World Journal of Hepatology, 2010, 2 (07) : 275 - 288
  • [38] Nonalcoholic Fatty Liver Disease in Pediatrics
    Duncan, Martin
    Zong, Wenjing
    Biank, Vincent F.
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2016, 45 (02): : E54 - E58
  • [39] Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease
    Khurana, Tarush
    Klepper, Corie
    Fei, Lin
    Sun, Qin
    Bramlage, Kristin
    Arce-Clachar, Ana Catalina
    Xanthakos, Stavra
    Mouzaki, Marialena
    JOURNAL OF PEDIATRICS, 2022, 250 : 61 - +
  • [40] The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
    Ryan, Jamie L.
    Sherman, Ashley K.
    Heble, Daniel E.
    Friesen, Craig A.
    Daniel, James F.
    Fischer, Ryan T.
    Slowik, Voytek
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (09): : 2241 - 2250